Skip to content

Details

Join NeuroTechX (NTX) for an evening to celebrate the incredibly rich and diverse Toronto neurotechnology community.

With support from Branch Out (branchoutfoundation.com), and in collaboration with student clubs NeuroTechUofT & NeuroTechYU, NeuroTechTO will host a gathering of neurotechnology enthusiasts for a panel discussion on the current and future impact of neurotechnological solutions to neurological and neuropsychiatric conditions being developed right here in Toronto, Canada.

The panel will feature participation from academic and industry experts, and will be followed by featured research and startup pitches.

---agenda---

6:30pm EDT – Event begins
6:35pm EDT – NeuroTechX introduction
6:40pm EDT – Branch Out introduction
6:45pm EDT – Panel talks begin
7:45pm EDT – Project pitches begin
8:30pm EDT – Event ends

If you would like to participate as an exhibitor during the online networking or pitch a project (research, industry, entrepreneur) at this event, please email chapters@neurotechx.com.

Panelist speaker bios:

Ms. Julia Rybkina is Patient Research Liaison for the Toronto Rehabilitation Institute. Ms. Rybkina’s work has focused on stopping memory decline in Multiple Sclerosis (MS) patients using a simple and accessible intervention: Google Street View. Julia’s research focuses on understanding the effectiveness of this intervention and developing the best strategies to deliver it.

Dr. Jean-Philippe Miron, M.D, FRCPC, is currently an Assistant Clinical Professor (Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal), co-directs the Psychiatric Neuromodulation Unit with Dr Paul Lespérance at the Centre Hospitalier de l’Université de Montréal (CHUM), and is a Principal Scientist at the Centre de Recherche du CHUM (CRCHUM). He specializes in the clinical application and development of innovative treatment strategies in refractory psychiatric disorders, including repetitive transcranial magnetic stimulation (rTMS), vagus nerve stimulation (VNS) and transcranial direct current stimulation (tDCS), while also providing advanced psychopharmacological treatments. His research interests focus on developing more efficient brain stimulation therapies as well as developing biomarkers for response prediction.

Dr. Andreea Diaconescu is an Independent Scientist at the Krembil Centre for Neuroinformatics at CAMH.Prior to this, she has been an SNF Ambizione fellow and Junior Group Leader at the University in Basel, Department of Psychiatry leading a project on early detection and treatment of psychosis using mathematical modelling. After completing her PhD in Cognitive Neuroscience at the Rotman Research Institute, University of Toronto, Dr. Diaconescu held a postdoctoral position at the Translational Neuromodeling Unit, University of Zurich and ETH Zurich. There, she developed and applied (neuro)computational models of learning and decision-making to understand the emergence and persistence of delusions in psychoaffective disorders such as schizophrenia. Dr. Diaconescu maintains collaborations in Switzerland, Germany, Netherlands, Italy, and the UK focused on symptom-specific modelling of multimodal neuroimaging data in the context of neuropsychiatric diseases.

You may also like